SAN DIEGO - TelAve -- Connect, the nonprofit organization supporting San Diego's innovation ecosystem for more than 40 years, today spotlights ReefHaven Ventures, an early-stage venture fund backing MedTech innovation at the convergence of artificial intelligence and robotics, from seed through Series A investments..

Founded by experienced operators, entrepreneurs, and investors, ReefHaven Ventures is focused on supporting founders building technologies that move from breakthrough ideas to meaningful patient impact. The fund provides early capital, operational guidance, investor perspective, and access to an ecosystem designed to help healthcare companies reach critical clinical and commercial milestones.

ReefHaven is led by UC San Diego Alum Garrett Smith, PhD, Managing Partner, and Nicholas Mourlas, PhD, Investment Partner. Together, they bring deep experience across company formation, venture investing, medical device innovation, and commercialization. Their backgrounds include founding, scaling, and exiting companies, as well as investing in and supporting companies across life sciences and MedTech.

More on TelAve News

• Strategic Talent Associates Launches THE ALIGNED RESET™
• Calvetta Phair Founder & CEO Earns AOPA Foundation Flight Training Scholarship, Inspiring a New Generation of STEM Dreamers in Underserved Communities
• MTV EMA Nominee and WOA Founder Oliver Sean Conferred Doctor of Musical Arts (DMA) Degree
• Karen D. Gentry Announces New Book Focused on Relationships and Personal Growth
• New plusOne Research Finds the Orgasm Gap Is a 30-Point Chasm — and Confirms It Isn't Biology

"ReefHaven represents the kind of capital partner that strengthens San Diego's innovation economy," said James Zanewicz, CEO of Connect. "The team understands what founders face at the earliest stages because they have built, funded, and scaled companies themselves. That operating experience matters, especially in healthcare, where the path from concept to commercialization requires both technical depth and trusted networks."

ReefHaven Ventures is also an active partner within the UC San Diego innovation ecosystem, including close collaboration with the MedTech Accelerator, which is affiliated with the Institute for the Global Entrepreneur at the Jacobs School of Engineering. Notably, ReefHaven's investment in KatoMed, a company developing surgical navigation technology to improve accuracy and workflow in spine procedures, was sourced and initially vetted through the MedTech Accelerator. The MedTech Accelerator serves as a critical, campus-wide resource, supporting startups across UC San Diego, including students, faculty, clinicians, and alumni. ReefHaven Ventures also co-invested alongside Kyocera Ventures in this seed round.

More on TelAve News

• CCHR Report Links 145 Violent Incidents to Psychiatric Drug Exposure, Urges National Oversight and Action
• Food Journal Magazine Unveils Its Latest 'Best of Los Angeles' Culinary Discoveries
• Boston Industrial Solutions Launches Natron® 717S Series: A New Flexible UV LED Ink for Ricoh GH2220 Printheads
• 5 Things NYC Courier Services Won't Tell You About How Same-Day Delivery Actually Works
• Tropidelic Links Up With International Reggae Star Collie Buddz and Eli Mac for Feel-Good Breakthrough Single "Follow Your Nature"

KatoMed reflects the type of opportunity ReefHaven was built to support: clinically grounded, technically differentiated, and rooted in strong collaboration across academia, engineering, medicine, and strategic industry partners.

As San Diego continues to grow as a center for life science and technology innovation, ReefHaven's emergence adds another important layer to the region's capital landscape, helping early-stage healthcare founders access the funding, expertise, and relationships needed to build enduring companies.

Learn more about ReefHaven Ventures at https://reefhavenventures.com/.